Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group Report

Stephanie J. Lee, Daniel Wolff, Carrie Kitko, John Koreth, Yoshihiro Inamoto, Madan Jagasia, Joseph Pidala, Attilio Olivieri, Paul J. Martin, Donna Przepiorka, Iskra Pusic, Fiona Dignan, Sandra A. Mitchell, Anita Lawitschka, David Jacobsohn, Anne M. Hall, Mary E D Flowers, Kirk R. Schultz, Georgia Boyce Vogelsang, Steven Pavletic

Research output: Contribution to journalArticle

Abstract

In 2005, the National Institutes of Health (NIH) Chronic Graft-versus-Host Disease (GVHD) Consensus Response Criteria Working Group recommended several measures to document serial evaluations of chronic GVHD organ involvement. Provisional definitions of complete response, partial response, and progression were proposed for each organ and for overall outcome. Based on publications over the last 9 years, the 2014 Working Group has updated its recommendations for measures and interpretation of organ and overall responses. Major changes include elimination of several clinical parameters from the determination of response, updates to or addition of new organ scales to assess response, and the recognition that progression excludes minimal, clinically insignificant worsening that does not usually warrant a change in therapy. The response definitions have been revised to reflect these changes and are expected to enhance reliability and practical utility of these measures in clinical trials. Clarification is provided about response assessment after the addition of topical or organ-targeted treatment. Ancillary measures are strongly encouraged in clinical trials. Areas suggested for additional research include criteria to identify irreversible organ damage and validation of the modified response criteria, including in the pediatric population.

Original languageEnglish (US)
Pages (from-to)984-999
Number of pages16
JournalBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Volume21
Issue number6
DOIs
StatePublished - Jun 1 2015

Fingerprint

National Institutes of Health (U.S.)
Graft vs Host Disease
Consensus
Clinical Trials
Publications
Pediatrics
Therapeutics
Research
Population
Recognition (Psychology)

Keywords

  • Allogeneic hematopoietic cell transplantation
  • Chronic graft-versus-host disease
  • Consensus
  • Guidelines
  • Response criteria

ASJC Scopus subject areas

  • Transplantation
  • Hematology

Cite this

Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease : IV. The 2014 Response Criteria Working Group Report. / Lee, Stephanie J.; Wolff, Daniel; Kitko, Carrie; Koreth, John; Inamoto, Yoshihiro; Jagasia, Madan; Pidala, Joseph; Olivieri, Attilio; Martin, Paul J.; Przepiorka, Donna; Pusic, Iskra; Dignan, Fiona; Mitchell, Sandra A.; Lawitschka, Anita; Jacobsohn, David; Hall, Anne M.; Flowers, Mary E D; Schultz, Kirk R.; Vogelsang, Georgia Boyce; Pavletic, Steven.

In: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, Vol. 21, No. 6, 01.06.2015, p. 984-999.

Research output: Contribution to journalArticle

Lee, Stephanie J. ; Wolff, Daniel ; Kitko, Carrie ; Koreth, John ; Inamoto, Yoshihiro ; Jagasia, Madan ; Pidala, Joseph ; Olivieri, Attilio ; Martin, Paul J. ; Przepiorka, Donna ; Pusic, Iskra ; Dignan, Fiona ; Mitchell, Sandra A. ; Lawitschka, Anita ; Jacobsohn, David ; Hall, Anne M. ; Flowers, Mary E D ; Schultz, Kirk R. ; Vogelsang, Georgia Boyce ; Pavletic, Steven. / Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease : IV. The 2014 Response Criteria Working Group Report. In: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2015 ; Vol. 21, No. 6. pp. 984-999.
@article{38ef20b296d8470eaaf84d5349783fe4,
title = "Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group Report",
abstract = "In 2005, the National Institutes of Health (NIH) Chronic Graft-versus-Host Disease (GVHD) Consensus Response Criteria Working Group recommended several measures to document serial evaluations of chronic GVHD organ involvement. Provisional definitions of complete response, partial response, and progression were proposed for each organ and for overall outcome. Based on publications over the last 9 years, the 2014 Working Group has updated its recommendations for measures and interpretation of organ and overall responses. Major changes include elimination of several clinical parameters from the determination of response, updates to or addition of new organ scales to assess response, and the recognition that progression excludes minimal, clinically insignificant worsening that does not usually warrant a change in therapy. The response definitions have been revised to reflect these changes and are expected to enhance reliability and practical utility of these measures in clinical trials. Clarification is provided about response assessment after the addition of topical or organ-targeted treatment. Ancillary measures are strongly encouraged in clinical trials. Areas suggested for additional research include criteria to identify irreversible organ damage and validation of the modified response criteria, including in the pediatric population.",
keywords = "Allogeneic hematopoietic cell transplantation, Chronic graft-versus-host disease, Consensus, Guidelines, Response criteria",
author = "Lee, {Stephanie J.} and Daniel Wolff and Carrie Kitko and John Koreth and Yoshihiro Inamoto and Madan Jagasia and Joseph Pidala and Attilio Olivieri and Martin, {Paul J.} and Donna Przepiorka and Iskra Pusic and Fiona Dignan and Mitchell, {Sandra A.} and Anita Lawitschka and David Jacobsohn and Hall, {Anne M.} and Flowers, {Mary E D} and Schultz, {Kirk R.} and Vogelsang, {Georgia Boyce} and Steven Pavletic",
year = "2015",
month = "6",
day = "1",
doi = "10.1016/j.bbmt.2015.02.025",
language = "English (US)",
volume = "21",
pages = "984--999",
journal = "Biology of Blood and Marrow Transplantation",
issn = "1083-8791",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease

T2 - IV. The 2014 Response Criteria Working Group Report

AU - Lee, Stephanie J.

AU - Wolff, Daniel

AU - Kitko, Carrie

AU - Koreth, John

AU - Inamoto, Yoshihiro

AU - Jagasia, Madan

AU - Pidala, Joseph

AU - Olivieri, Attilio

AU - Martin, Paul J.

AU - Przepiorka, Donna

AU - Pusic, Iskra

AU - Dignan, Fiona

AU - Mitchell, Sandra A.

AU - Lawitschka, Anita

AU - Jacobsohn, David

AU - Hall, Anne M.

AU - Flowers, Mary E D

AU - Schultz, Kirk R.

AU - Vogelsang, Georgia Boyce

AU - Pavletic, Steven

PY - 2015/6/1

Y1 - 2015/6/1

N2 - In 2005, the National Institutes of Health (NIH) Chronic Graft-versus-Host Disease (GVHD) Consensus Response Criteria Working Group recommended several measures to document serial evaluations of chronic GVHD organ involvement. Provisional definitions of complete response, partial response, and progression were proposed for each organ and for overall outcome. Based on publications over the last 9 years, the 2014 Working Group has updated its recommendations for measures and interpretation of organ and overall responses. Major changes include elimination of several clinical parameters from the determination of response, updates to or addition of new organ scales to assess response, and the recognition that progression excludes minimal, clinically insignificant worsening that does not usually warrant a change in therapy. The response definitions have been revised to reflect these changes and are expected to enhance reliability and practical utility of these measures in clinical trials. Clarification is provided about response assessment after the addition of topical or organ-targeted treatment. Ancillary measures are strongly encouraged in clinical trials. Areas suggested for additional research include criteria to identify irreversible organ damage and validation of the modified response criteria, including in the pediatric population.

AB - In 2005, the National Institutes of Health (NIH) Chronic Graft-versus-Host Disease (GVHD) Consensus Response Criteria Working Group recommended several measures to document serial evaluations of chronic GVHD organ involvement. Provisional definitions of complete response, partial response, and progression were proposed for each organ and for overall outcome. Based on publications over the last 9 years, the 2014 Working Group has updated its recommendations for measures and interpretation of organ and overall responses. Major changes include elimination of several clinical parameters from the determination of response, updates to or addition of new organ scales to assess response, and the recognition that progression excludes minimal, clinically insignificant worsening that does not usually warrant a change in therapy. The response definitions have been revised to reflect these changes and are expected to enhance reliability and practical utility of these measures in clinical trials. Clarification is provided about response assessment after the addition of topical or organ-targeted treatment. Ancillary measures are strongly encouraged in clinical trials. Areas suggested for additional research include criteria to identify irreversible organ damage and validation of the modified response criteria, including in the pediatric population.

KW - Allogeneic hematopoietic cell transplantation

KW - Chronic graft-versus-host disease

KW - Consensus

KW - Guidelines

KW - Response criteria

UR - http://www.scopus.com/inward/record.url?scp=84940923718&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940923718&partnerID=8YFLogxK

U2 - 10.1016/j.bbmt.2015.02.025

DO - 10.1016/j.bbmt.2015.02.025

M3 - Article

C2 - 25796139

AN - SCOPUS:84940923718

VL - 21

SP - 984

EP - 999

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

SN - 1083-8791

IS - 6

ER -